Instructional Course - Requires Course Pass, Additional Registration Required

Instructional Course

078IC - Management of Prostate Cancer: A Case-Based Approach with Emphasis on Integrating New Molecular Diagnostics into Clinical Practice

Monday, May 21
4:00 PM - 6:00 PM
Location: MCC WEST, 2004

This course will provide a practical, evidence-based approach for the management of everyday problems in the management of prostate cancer, using a case-based approach with examples from real practice. Cases will illustrate contemporary management of early and late stage disease with emphasis on how new molecular diagnostic and prognostic tests (PCA3, MDx Confirm, Mitomics, Prolaris, Oncotype Dx Prostate, Decipher, and others) can be used for improved clinical decision making in screening, decisions on initial biopsy and rebiopsy, choosing and following men for active surveillance, and managing PSA failures. In addition, best practice use of newer agents for management of castrate-resistant disease will be reviewed, including the potential for use of targeted therapies based on genomic analysis of advanced tumors. The course will be of interest to individuals at all levels of clinical experience.

Learning Objectives:

Eric Klein

Glickman Urological and Kidney Institute, Cleveland Clinic

Eric A. Klein, MD is the Andrew C. Novick Distinguished Chair of the Glickman Urological and Kidney Institute and Professor of Surgery in the Lerner College of Medicine of the Cleveland Clinic. Following undergraduate training at Johns Hopkins University, he was a cum laude graduate of the University of Pittsburgh School of Medicine. He subsequently completed residency training in Urology at the Cleveland Clinic and a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center. He joined the staff of the Cleveland Clinic in 1989 and currently serves as a member of the Department of Cancer Biology of the Cleveland Clinic Lerner Research Institute, the Taussig Cancer Institute, and the Genitourinary Malignancies Program in the Case Comprehensive Cancer Center. He served as President of the Society of Urologic Oncology from 2009 - 2011.

Dr. Klein’s clinical and research interests cover all stages of prostate cancer with a focus on genomics and clinical trials. Dr. Klein has contributed > 400 papers to the scientific literature, authored/ edited 8 books on urologic malignancies, and serves as the Editor-in-Chief of Urology. He has delivered > 200 invited scientific lectures including 13 named lectureships, and has served as a Visiting Professor at > 50 institutions around the world. Dr. Klein was awarded the F. Mason Sones Innovation Award by the Cleveland Clinic in 2009, The Joe V. Meigs Award by the Society of Pelvic Surgeons in 2013 and 2015, and has received 3 Career Achievement Awards including a 2014 Presidential Citation from the AUA the 2014 Huggins Medal from the Society of Urologic Oncology, and the 2015 Philip S. Hench Award from the University of Pittsburgh School of Medicine. He is currently co-PI on two Prostate Cancer Foundation Challenge Grants, and co-leader of the Cleveland Clinic Lerner Research Institute-designated Prostate Cancer Center of Excellence.

Presentation(s):

Send Email for Eric Klein

Andrew J. Stephenson

Cleveland Clinic

Andrew Stephenson, M.D., is the Director for the Center of Urologic Oncology at Cleveland Clinic's Glickman Urological and Kidney Institute. His clinical and research focus is the treatment of patients with cancers of prostate, bladder, testis, and kidney. He has published over 100 articles in peer-reviewed journals on issues related to prostate, bladder, kidney and testis cancer. Dr. Stephenson is board-certified in urology by the American Board of Urology and the Royal College of Physicians and Surgeons of Canada. He has received several awards from organizations such as the Prostate Cancer Foundation, American Society of Clinical Oncology, and Society of Urologic Oncology. He is listed as one of the Best Doctors in America. He is a past recipient of the Urology Teacher of the Year award from Cleveland Clinic and the Young Investigator Award from the Society of Urologic Oncology. He has also been recognized as a Rising Star in Urology by the American Urological Association. Dr. Stephenson receives grant support for prostate cancer research from the Robert Wood Johnson Foundation, American Cancer Society, and the Urology Care Foundation. His research focus is on improving decision-making for patients and physicians for complex urological cancers. He is on the editorial board for several urology and oncology journals.

Presentation(s):

Send Email for Andrew Stephenson


Assets

078IC - Management of Prostate Cancer: A Case-Based Approach with Emphasis on Integrating New Molecular Diagnostics into Clinical Practice



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Management of Prostate Cancer: A Case-Based Approach with Emphasis on Integrating New Molecular Diagnostics into Clinical Practice